NCT01156012View on ClinicalTrials.gov

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

404

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Glaucoma

Interventions

DRUG

T2345

One drop of T2345

DRUG

Prostaglandin

One drop

Trial Locations (1)

63000

Medical Director, Clermont-Ferrand

Sponsors

Lead Sponsor

Laboratoires Thea

All Listed Sponsors

lead

Laboratoires Thea

INDUSTRY